Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 1999

View Archived Issues

Bristol-Myers Squibb pioneers pharmacogenomic approach to cancer therapy, enters new alliance

Inosine dramatically stimulates axonal regeneration

Preliminary survival data from single Maxamine site submitted to ASCO

SuperGen and Stehlin Foundation extend research and licensing agreement

Combination A6 and tamoxifen effective in rat breast tumor

Financial results and R&D highlights at Texas Biotechnology

Protein Sciences and Pasteur Merieux Connaught expand influenza collaboration

New taxane analogue from Bristol-Myers Squibb now in phase I testing

Microcide's novel cephalosporin antibiotic enters the clinic

U.S. academic team takes a novel approach to treating prostate cancer

Following pre-NDA meeting, Genelabs to seek approval of GL-701 for treatment of SLE

Anticoagulant serine protease inhibitors described by 3-D

Novel Y5 receptor ligands in development at Ortho-McNeil for obesity and other disorders

Inhibitors of Na+/H+ exchange disclosed by Fujisawa

Agents for ulcers and other GI disorders under study at AstraZeneca

VEGF receptor tyrosine kinase inhibitor PTK-787 is a potent antiangiogenic agent

Merck's new PDE5 inhibitors useful for impotence, cardiovascular disorders

Topical antifungal agents with in vitro and in vivo efficacy developed at Hanwha

Multiple-dose PK and safety data reported at AAPS meeting for pregabalin

Bayer presents novel camptothecin glycoconjugates at AACR-NCI-EORTC meeting

Influence of cardiac output on clearance of dexmedetomidine

Darbufelone: bioavailability, multiple-dose PK, interactions with MTX discussed at AAPS

European screening program identifies novel anticancer drug candidate

Radicicol derivative KF-58333 is a promising antileukemia agent

More promising cancer news from AACR-NCI-EORTC: Hughes Institute presents new compounds

FDA approves Aggrenox for prevention of recurrent stroke

Timetable for Shire-Roberts merger

InKine seeks FDA approval of Diacol

Palatin Technologies submits BLA for LeuTech imaging agent

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...